2021
Treatment of Primary Aldosteronism Increases Plasma Epoxyeicosatrienoic Acids
Luther JM, Wei DS, Ghoshal K, Peng D, Adler GK, Turcu AF, Nian H, Yu C, Solorzano CC, Pozzi A, Brown NJ. Treatment of Primary Aldosteronism Increases Plasma Epoxyeicosatrienoic Acids. Hypertension 2021, 77: 1323-1331. PMID: 33583202, PMCID: PMC8320355, DOI: 10.1161/hypertensionaha.120.14808.Peer-Reviewed Original Research
2016
B-Type Natriuretic Peptide, Aldosterone, and Fluid Management in ARDS
Semler MW, Marney AM, Rice TW, Nian H, Yu C, Wheeler AP, Brown NJ, Network N. B-Type Natriuretic Peptide, Aldosterone, and Fluid Management in ARDS. CHEST Journal 2016, 150: 102-111. PMID: 27018313, PMCID: PMC4980545, DOI: 10.1016/j.chest.2016.03.017.Peer-Reviewed Original ResearchConceptsB-type natriuretic peptideAcute respiratory distress syndromeConservative fluid managementRespiratory distress syndromeLiberal fluid managementVentilator-free daysNatriuretic peptideFluid managementDistress syndromeAldosterone concentrationOverall mortalityB-type natriuretic peptide concentrationsCatheter Treatment TrialNatriuretic peptide concentrationsLow aldosterone concentrationsHospital mortalityMedian aldosteroneMultivariable analysisStudy enrollmentTreatment trialsPlasma concentrationsRetrospective analysisFluid balanceAldosteroneFluid strategy
2002
Improving Medication Use in Newly Admitted Home Healthcare Patients: A Randomized Controlled Trial
Meredith S, Feldman P, Frey D, Giammarco L, Hall K, Arnold K, Brown NJ, Ray WA. Improving Medication Use in Newly Admitted Home Healthcare Patients: A Randomized Controlled Trial. Journal Of The American Geriatrics Society 2002, 50: 1484-1491. PMID: 12383144, DOI: 10.1046/j.1532-5415.2002.50402.x.Peer-Reviewed Original ResearchMeSH KeywordsAgedDrug TherapyFollow-Up StudiesHome Care AgenciesHome Care ServicesHumansInterviews as TopicOutcome Assessment, Health CareConceptsHome health agenciesMedication useNonsteroidal antiinflammatory drugsMedication problemsHome care nursesTherapeutic duplicationUsual careIntervention patientsControl patientsHealth agenciesIntervention effectsPeptic ulcer complicationsProportion of patientsHome healthcare patientsLarge home health agencyHome health careAdverse intervention effectsUlcer complicationsCardiovascular medicationsQualifying patientsControlled TrialsAdrenergic effectsClinical pharmacistsNurse visitsTrial endpoints